Oracle Stock at $132.60: Revenue Growth Meets Capex and Credit Pressure

Oracle shares have fallen sharply even as revenue growth accelerates, with investors focusing on heavy capital spending, negative free cash flow and financing risk. The next key catalyst is Oracle’s October 28 analyst day.

Oracle stock closed at $132.60 after another volatile session, leaving the software and cloud company nearly 59% below its 52-week high despite posting record operating results. The disconnect has become the core market debate: strong growth and backlog on one side, capital intensity and credit concerns on the other.

The stock’s latest slide came as investors weighed a $664 billion remaining performance obligation, quarterly revenue of $19.3 billion, and a steep $28 billion capital expenditure figure that pushed free cash flow to negative $5 billion. That mix has shifted attention from Oracle’s AI growth story to the durability of its financing model.

With Oracle now trading at about 16.4 times fiscal 2027 non-GAAP earnings guidance of $8.10 per share, the valuation looks far cheaper than it did a year ago. The question for investors is whether the lower multiple reflects opportunity or a market warning about execution, funding costs, and customer concentration.

Key Facts

  • Oracle closed at $132.60, down 3.28%, with a market capitalization of about $401 billion.
  • Fiscal first-quarter revenue reached $19.3 billion, up 30% year over year, while cloud revenue rose 62% to $11.6 billion.
  • Oracle’s remaining performance obligations climbed to $664 billion, including more than $30 billion in new AI cloud contracts in the quarter.
  • Quarterly capital expenditures were $28 billion, and free cash flow was negative $5 billion.
  • The stock trades at roughly 16.4 times Oracle’s fiscal 2027 non-GAAP EPS guidance of $8.10.

Oracle stock

Oracle’s recent selloff reflects a sharp change in what investors care about. For much of the past year, the market rewarded the company for surging demand in cloud infrastructure and AI-related capacity. That enthusiasm was fueled by triple-digit growth in cloud infrastructure, a rapidly expanding contract backlog, and investor belief that Oracle could become a major beneficiary of large-scale AI computing demand.

That narrative has not disappeared, but it is now competing with concerns about balance-sheet strain. Oracle delivered a strong quarter on revenue, profit and guidance, yet the stock still fell because investors focused on the cost of building enough data-center capacity to fulfill its commitments. Heavy spending, external fundraising, and rising interest rates have made the market less willing to overlook negative free cash flow, even when backlog growth remains robust.

The issue matters beyond Oracle shareholders. The company sits at the intersection of enterprise software, cloud infrastructure, AI buildouts, and credit markets. If Oracle can convert contracted demand into profitable revenue without overextending its capital base, the current valuation may look conservative. If not, the stock could remain under pressure as investors apply a discount for financing risk rather than reward for growth.

Oracle is no longer being judged only on how fast its AI backlog is growing, but on whether it can finance that growth without damaging shareholder returns.

Why the market is focused on cash and credit

Oracle’s fiscal first-quarter numbers were impressive on the surface. Cloud infrastructure revenue rose 121% to $7.4 billion, cloud applications revenue reached $4.2 billion, and non-GAAP EPS of $1.92 topped expectations. Management also raised full-year guidance, projecting at least $90 billion in fiscal 2027 revenue, up 34%, with non-GAAP EPS of $8.10.

But investors zeroed in on the funding side of the equation. Capital expenditures hit $28 billion in the quarter, while net cash capex was about $18 billion after customer prepayments and hardware arrangements. The company’s ability to sustain this buildout depends on backlog conversion, customer demand staying intact, and access to capital at acceptable rates. That is why developments tied to project financing, pledged shares, and debt pricing have had an outsized effect on sentiment.

Another important variable is project execution. A force majeure notice tied to a major New Mexico data-center development raised questions about timing, even though the underlying lease commitments remain in place. The episode highlighted how sensitive Oracle’s equity has become to any signal that delays, permitting issues, or infrastructure bottlenecks could push out revenue realization while capital commitments continue.

Implications for Investors

For investors, Oracle presents a classic tension between growth and financial discipline. On one hand, the company has one of the largest contracted backlogs in large-cap technology, and its cloud infrastructure growth rate remains well above many larger rivals. Trading at around 16.4 times forward earnings guidance, the stock is significantly cheaper than many other cloud and AI-linked names.

On the other hand, the discount is not arbitrary. Oracle’s AI expansion requires enormous spending, and the market is demanding proof that those investments can be funded with manageable leverage and converted into cash-generating revenue. Investors should watch three areas closely: the pace of backlog conversion, the trajectory of net cash capex, and any signs of stress in customer demand or project timelines.

Portfolio positioning depends on risk tolerance. Value-oriented investors may see a company with 30%-plus revenue growth trading at a compressed multiple. More conservative investors may prefer to wait for evidence that free cash flow is stabilizing and that major infrastructure projects are moving forward without further financing concerns. Volatility is also likely to remain elevated, especially as Treasury yields, credit spreads, and AI spending expectations continue to shape sentiment.

The next major catalyst is Oracle’s October 28 analyst day, where management is expected to address capital spending, capacity rollout, and the path from backlog to revenue. Until then, Oracle stock is likely to trade less on reported growth alone and more on whether investors regain confidence in the balance sheet supporting that growth.

Ultima Markets